Suzanne M Cadarette

10PUBLICATIONS
19CO-AUTHORS
Epidemiological methodsPharmacogenomicsPeriodonticsBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 21, 2025
A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture risk.

Maria C Spagnuolo, Freddy F Shogry, Stephen Park

|Mar 24, 2023
Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data.

Natalia Konstantelos, Andrea M Burden, Angela M Cheung

|Jan 10, 2022
Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy : A Propensity Score-Matched Cohort Study.

Kaleen N Hayes, Kevin A Brown, Angela M Cheung

|Apr 03, 2021
Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making.

Kaleen N Hayes, Elizabeth M Winter, Suzanne M Cadarette

|Mar 14, 2021
Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.

Suzanne M Cadarette, Malcolm Maclure, J A Chris Delaney

|Jul 19, 2019
Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.

J K Ban, B B Hao, L McCarthy

Pageof 2

Frequent Collaborators

4 joint publications

Kaleen N Hayes

3 joint publications

Andrea M Burden

1 joint publications

Brian Chun-Fai Chan

1 joint publications

J A Chris Delaney